TDO2 is constitutively expressed in various cancer cells, such as hepatocarcinoma, bladder carcinoma, breast carcinoma, colorectal carcinoma, lung carcinoma, and glioblastoma, playing a role in immune surveillance and tumor biology (6, 8, 9). This evidence concerns the gene TDO2 and breast carcinoma.